Should I buy or sell Know Labs stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" KNW shares. View KNW analyst ratings or view top-rated stocks .

What is Know Labs' stock price target for 2024?

1 Wall Street research analysts have issued 12 month price targets for Know Labs' shares. Their KNW share price targets range from $1.00 to $1.00. On average, they expect the company's stock price to reach $1.00 in the next year. This suggests a possible upside of 79.2% from the stock's current price. View analysts price targets for KNW or view top-rated stocks among Wall Street analysts .

How were Know Labs' earnings last quarter?

Know Labs, Inc. (NYSEAMERICAN:KNW) issued its earnings results on Wednesday, February, 14th. The company reported ($0.04) earnings per share for the quarter.

Who are Know Labs' major shareholders?

Know Labs' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Foguth Wealth Management LLC. (0.12%). Insiders that own company stock include Ichiro John Paul Takesako, Jessica English, Leonardo Mouta Trautwein, Ronald P Erickson and William Arthur Owens. View institutional ownership trends .

How do I buy shares of Know Labs?

Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:KNW

Know Labs (KNW) Stock Price, News & Analysis

→ Start loving Mondays like this (From DTI) (Ad)

Free KNW Stock Alerts

$0.56

-0.07 (-11.15%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.55
▼
$0.63
50-Day Range: N/A
52-Week Range: $0.23
▼
$1.48

Volume: 158,453 shs
Average Volume: 125,961 shs
Market Capitalization: $45.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $1.00

Stock Analysis Analyst Forecasts Chart Earnings Headlines Insider Trades Ownership Short Interest

Get Know Labs alerts:

Know Labs MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 79.2% Upside
$1.00 Price Target
Short Interest: Healthy
0.66% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.67 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Know Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
Know Labs has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.66% of the float of Know Labs has been sold short.
Short Interest Ratio / Days to Cover
Know Labs has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Know Labs has recently increased by 0.99%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Know Labs does not currently pay a dividend.
Dividend Growth
Know Labs does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for KNW.

3.0

News and Social Media Coverage

News Sentiment
Know Labs has a news sentiment score of 1.34. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Business Services companies.
MarketBeat Follows
4 people have added Know Labs to their MarketBeat watchlist in the last 30 days. This is an increase of 33% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Know Labs insiders have not sold or bought any company stock.
Percentage Held by Insiders
13.70% of the stock of Know Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 23.96% of the stock of Know Labs is held by institutions.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Know Labs is -1.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Know Labs is -1.51, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Know Labs has a P/B Ratio of 11.16. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

Click here to get them (for Free).

About Know Labs Stock (NYSEAMERICAN:KNW)

Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States. The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.

KNW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

KNW Stock News Headlines

April 9, 2024 | americanbankingnews.com

Know Labs (NYSEAMERICAN:KNW) Research Coverage Started at Benchmark

April 5, 2024 | businesswire.com

Know Labs to Present Clinical Research at the 2024 American Physiology Summit

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

March 8, 2024 | stockhouse.com

Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study

March 6, 2024 | finance.yahoo.com

Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study

March 2, 2024 | uk.investing.com

Know Labs secures $12 million investment from Lind

February 29, 2024 | msn.com

Know Labs secures $12M funding for further execution on clinical research and development initiatives

February 29, 2024 | finance.yahoo.com

Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives

April 17, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

February 29, 2024 | businesswire.com

Know Labs Secures U.S. $12 Million Funding for Company's Further Execution on Its Clinical Research and Development Initiatives

February 27, 2024 | stockhouse.com

Know Labs Announces the KnowU(TM), its Wearable Non-Invasive Continuous Glucose Monitor

February 27, 2024 | businesswire.com

Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor

February 15, 2024 | msn.com

Know Labs, Inc. (NYSE:KNW) Q1 2024 Earnings Call Transcript

February 14, 2024 | finance.yahoo.com

Know Labs, Inc. Reports First Quarter FY2024 Results

February 14, 2024 | businesswire.com

Know Labs, Inc. Reports First Quarter FY2024 Results

February 7, 2024 | finance.yahoo.com

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024

February 5, 2024 | msn.com

Western North Carolina lab begins testing for 'gas station heroin' on the heels of FDA warning

January 24, 2024 | msn.com

City of Reedley, Fresno County to receive $260K for illegal lab cleanup

January 23, 2024 | finance.yahoo.com

Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

December 21, 2023 | finance.yahoo.com

Know Labs, Inc. (NYSE:KNW) Q4 2023 Earnings Call Transcript

December 19, 2023 | investorplace.com

KNW Stock Earnings: Know Labs Reported Results for Q4 2023

December 19, 2023 | msn.com

Know Labs GAAP EPS of -$0.41

December 19, 2023 | finance.yahoo.com

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results

December 11, 2023 | finance.yahoo.com

Know Labs, Inc. to Host Review of Fiscal Year 2023 Results on December 19, 2023

November 8, 2023 | finance.yahoo.com

Know Labs Expands Board of Directors

September 27, 2023 | news.yahoo.com

Clinic, lab expansion to get 'dirty'

September 27, 2023 | benzinga.com

Why Know Labs (KNW) Stock Hit A New 52-Week Low Today

See More Headlines

Receive KNW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/14/2024
Today: 4/17/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Business Services
Industry: Measuring & controlling devices, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:KNW
CUSIP: N/A
CIK: N/A
Web: www.knowlabs.co
Phone: (206) 903-1351
Fax: 206-826-0451
Employees: 12
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $1.00
High Stock Price Target: $1.00
Low Stock Price Target: $1.00
Potential Upside/Downside: +72.4%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.37)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-15,290,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -416.36%
Return on Assets: -152.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.27
Quick Ratio: 1.27

Sales & Book Value

Annual Sales: $4.36 million
Price / Sales: 10.82
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.05 per share
Price / Book: 11.60

Miscellaneous

Outstanding Shares: 81,350,000
Free Float: 70,202,000
Market Cap: $47.18 million
Optionable: Not Optionable
Beta: 1.63

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

Mr. Ronald P. Erickson J.D. (Age 80)
Founder, CEO, Treasurer & Chairman
Comp: $544.97k
Mr. Peter Joseph Conley
CFO & Senior VP of Intellectual Property
Ms. Jessica English (Age 38)
Chief Marketing Officer
Dr. James H. Anderson Jr.
M.D., Chief Medical Officer and Chairman of Medical, Scientific & Regulatory Advisory Board
Mr. Steven T. Kent
Chief Product Officer
Mr. Leonardo Trautwein (Age 42)
Chief Commercial Officer
Jordyn Hujar
Chief of Staff

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

KNW Stock Analysis - Frequently Asked Questions

Should I buy or sell Know Labs stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Know Labs in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" KNW shares.
View KNW analyst ratings or view top-rated stocks.
What is Know Labs' stock price target for 2024?: 1 Wall Street research analysts have issued 12 month price targets for Know Labs' shares. Their KNW share price targets range from $1.00 to $1.00. On average, they expect the company's stock price to reach $1.00 in the next year. This suggests a possible upside of 79.2% from the stock's current price.
View analysts price targets for KNW or view top-rated stocks among Wall Street analysts.
How were Know Labs' earnings last quarter?: Know Labs, Inc. (NYSEAMERICAN:KNW) issued its earnings results on Wednesday, February, 14th. The company reported ($0.04) earnings per share for the quarter.

Who are Know Labs' major shareholders?: Know Labs' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Foguth Wealth Management LLC. (0.12%). Insiders that own company stock include Ichiro John Paul Takesako, Jessica English, Leonardo Mouta Trautwein, Ronald P Erickson and William Arthur Owens.
View institutional ownership trends.
How do I buy shares of Know Labs?: Shares of KNW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:KNW) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial